Apria Appoints Healthcare Industry Veterans Susannah Gray and Terri Kline to Board of Directors
14 Maggio 2021 - 2:00PM
Apria, Inc. (the “Company” or “Apria”) (Nasdaq: APR) announced
today that it has appointed Susannah Gray and Terri Kline to the
Company’s Board of Directors. Both will serve on the Board’s Audit
Committee.
Gray possesses a wealth of experience in healthcare leadership,
serving in board of director and committee capacities at 4D
Molecular Therapeutics, Maravai Life Sciences, Morphic
Therapeutics, BioSplice Therapeutics, Wesleyan University, the
Susan G. Komen Foundation, Street Squash and the German Marshall
Fund. She also served as Executive Vice President and Chief
Financial Officer of Royalty Pharma, the largest aggregator of
pharmaceutical royalty interests worldwide, and held roles at Chase
Securities, Merrill Lynch and CIBC World Markets. Gray holds a
Master of Business Administration from Columbia University and a
Bachelor of Arts from Wesleyan University.
Kline brings to Apria deep expertise in healthcare advisory and
currently serves on the boards of Amedisys, Intersect ENT, SaVida
Health and Presbyterian Health Plan, Inc. Previously, she served as
Executive Vice President of Henry Ford Health System (HFHS), as
President and Chief Executive Officer of Health Alliance Plan – a
subsidiary of HFHS – and as Senior Vice President and Chief Health
Care Management Officer of Health Care Service Corporation. Kline
holds a Master of Public Health from the University of Michigan and
a Bachelor of Arts from Kalamazoo College.
“With decades of combined experience in healthcare leadership
and advisory, Susannah Gray and Terri Kline significantly
strengthen the expertise of our Company’s Board of Directors,” said
Dan Starck, Chief Executive Officer of Apria. “Our executive
leadership and board are pleased to add two individuals with their
stellar reputations, and both will undoubtedly help guide us
through our next phase of growth, as we continue to strive to
improve the quality of life for our patients at home.”
About Apria
Apria is a leading provider of integrated home healthcare
equipment and related services in the United States. The Company
offers a comprehensive range of products and services for in-home
care and delivery across three core service lines: (1) home
respiratory therapy (including home oxygen and non-invasive
ventilation (“NIV”) services); (2) obstructive sleep apnea
(“OSA”) treatment (including continuous positive airway pressure
(“CPAP”) and bi-level positive airway pressure devices, and patient
support services); and (3) negative pressure wound therapy
(“NPWT”). Additionally, the Company supplies a wide range of home
medical equipment and other products and services to help improve
the quality of life for patients with home care needs. Our revenues
are generated through fee-for-service and capitation arrangements
with payors for equipment, supplies, services and other items we
rent or sell to patients. Through our offerings, we also provide
patients with a variety of clinical and administrative support
services and related products and supplies, most of which are
prescribed by a physician as part of a care plan. We are focused on
being the industry’s highest-quality provider of home healthcare
equipment and related services, while maintaining our commitment to
being a low-cost operator. The Company serves over 2 million
patients annually and offers a compelling value proposition to
patients, providers and payors by allowing patients to receive
necessary care and services in the comfort of their own home,
while, at the same time, reducing the costs of treatment. Learn
more at www.apria.com.
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended. These statements include, but are not limited to,
statements regarding our expectations regarding the impact of the
COVID-19 public health emergency, the future performance and
financial results of our business and other non-historical
statements. Forward-looking statements include all statements
that do not relate solely to historical or current facts. In some
cases, you can identify these forward-looking statements by the use
of words such as “outlook,” “believes,” “expects,” “potential,”
“continues,” “may,” “will,” “should,” “could,” “seeks,” “predicts,”
“intends,” “trends,” “plans,” “estimates,” “anticipates” or the
negative version of these words or other comparable words. Such
forward-looking statements are subject to various risks and
uncertainties, including, among others, risks related to the
COVID-19 public health emergency, the profitability of our
capitation arrangements, renegotiation or termination of our
contracts, reimbursements by payors, our reliance on relatively few
vendors, competition in the home healthcare industry, the inherent
risk of liability in the provision of healthcare services, and
reductions in Medicare and Medicaid and commercial payor
reimbursement rates. Additional factors that could cause our
actual outcomes or results to differ materially from those
described in the forward-looking statements can be found in the
“Risk Factors" section of the Company’s Annual Report on Form 10-K
for the period ended December 31, 2020, and in its other filings
with the Securities and Exchange Commission (“SEC”). Additional
information will also be set forth in Apria’s Quarterly Report on
Form 10-Q for the period ended March 31, 2021, which is expected to
be filed on or about the date of this press release. These
reports are or will be accessible on the SEC’s website at
www.sec.gov. These factors should not be construed as exhaustive
and should be read in conjunction with the other cautionary
statements that are included in this press release and in the
Company’s filings with the SEC. We undertake no obligation to
publicly update or review any forward-looking statement, whether as
a result of new information, future developments or otherwise,
except as required by law.
Investor
ContactsBob.East@westwicke.com Kevin.ellich@westwicke.com
Media
ContactsMark.Corbae@westwicke.com Kyle.Evans@westwicke.com
Grafico Azioni Apria (NASDAQ:APR)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Apria (NASDAQ:APR)
Storico
Da Mag 2023 a Mag 2024